Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04263337Phase 1Active, not recruiting
Phase 1, open-label trial (10 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoints: PET Neuroimaging Standard Uptake Value Ratio, MRI Neuroimaging and 28 more. Started Mar 2020; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04263337.